benzimidazole has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 2 studies
1H-benzimidazole : The 1H-tautomer of benzimidazole.
Excerpt | Relevance | Reference |
---|---|---|
"Crystal structure analysis revealed key interactions of a 2-amino-benzimidazole viral translation inhibitor that captures an elongated conformation of an RNA switch target in the internal ribosome entry site (IRES) of hepatitis C virus (HCV)." | 3.83 | Ligand Optimization by Improving Shape Complementarity at a Hepatitis C Virus RNA Target. ( Boerneke, MA; Charrette, BP; Hermann, T, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Charrette, BP | 1 |
Boerneke, MA | 1 |
Hermann, T | 1 |
Randolph, JT | 1 |
Flentge, CA | 1 |
Donner, P | 1 |
Rockway, TW | 1 |
Patel, SV | 1 |
Nelson, L | 1 |
Hutchinson, DK | 1 |
Mondal, R | 1 |
Mistry, N | 1 |
Reisch, T | 1 |
Dekhtyar, T | 1 |
Krishnan, P | 1 |
Pilot-Matias, T | 1 |
Stolarik, DF | 1 |
Beno, DWA | 1 |
Wagner, R | 1 |
Maring, C | 1 |
Kati, WM | 1 |
2 other studies available for benzimidazole and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
Article | Year |
---|---|
Ligand Optimization by Improving Shape Complementarity at a Hepatitis C Virus RNA Target.
Topics: Antiviral Agents; Benzimidazoles; Drug Design; Hepacivirus; Hepatitis C; Humans; Internal Ribosome E | 2016 |
Discovery of fluorobenzimidazole HCV NS5A inhibitors.
Topics: Animals; Antiviral Agents; Benzimidazoles; Dogs; Genotype; Halogenation; Hepacivirus; Hepatitis C; H | 2016 |